Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

AUREOMYCIN 100G PREMIX DIN 02230724

Status: Cancelled Post Market
Holder: HOFFMANN-LA ROCHE LIMITED
Molecule: CHLORTETRACYCLINE HYDROCHLORIDE (CHLORTETRACYCLINE CALCIUM)

Health Canada record

Active ingredient(s)CHLORTETRACYCLINE HYDROCHLORIDE (CHLORTETRACYCLINE CALCIUM) 220 G
Dosage formDrug Premix
RouteOral
SchedulePRESCRIPTION
ClassVeterinary
ATC
Original market date11-Nov-1997
Current status date27-Jul-2000
SourceHealth Canada DPD

Establishment licence of the holder

Hoffmann-La Roche Limited — licence 100006, currently licensed, last inspection rating C (2024-06-25).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing CHLORTETRACYCLINE HYDROCHLORIDE (CHLORTETRACYCLINE CALCIUM)

DINProductCompanyFormStrengthStatus
02242817AUREOMYCIN 110 GZOETIS CANADA INCDrug PremixCHLORTETRACYCLINE HYDROCHLORIDE (CHLORTETRACYCLINE CALCIUM) 110 GCancelled Post Market
02230723AUREOMYCIN 50G PREMIXHOFFMANN-LA ROCHE LIMITEDDrug PremixCHLORTETRACYCLINE HYDROCHLORIDE (CHLORTETRACYCLINE CALCIUM) 110 GCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
65731998-09-15Supplement to a New Drug Submission (SNDS)ALTERNATE PACKAGING
64191997-02-27New Drug Submission (NDS)
Request a quote for AUREOMYCIN 100G PREMIX

How to read a Canadian DIN record